Clinical trials
Neonate clinical trials
Below are recruiting neonate clinical trials, each written for real people, not researchers. We’re tracking 319 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04239508Recruiting
Newborn brain-cooling and follow-up data study in Switzerland
This study follows Swiss babies after very early birth or after breathing/oxygen problems around delivery, to better understand outcomes and care. If your baby fits the timing or birth condition rules, their information may be collected for follow-up and research.
ZurichAges birth–4 weeks - NCT04777760Recruiting
Surfactant treatment for newborn breathing distress
This trial looks at giving a “surfactant” medicine (a substance that helps keep baby lungs open) to newborns who have serious breathing problems soon after birth. It may help babies with neonatal respiratory distress or acute breathing distress, especially if they’re treated in the early time window.
Chongqing, Chongqing MunicipalityAges 1 minute–1 day - NCT06878703RecruitingPhase 3
Dexmedetomidine vs midazolam for preterm babies on a ventilator
This study compares two sedative medicines, dexmedetomidine and midazolam, to see which one helps preterm babies on a ventilator breathe on their own sooner. Your baby may be eligible if they were born very early and need medicine to relax while on the breathing machine.
ParisAges Up to 7 months - NCT06832800RecruitingEarly Phase 1
Testing a new tool to manage jaundice in newborns
This trial uses a special breath test (ETCOc) to measure jaundice in newborns, aiming to improve diagnosis and treatment. It may help doctors decide when treatment is needed.
HangzhouAges 4 hours–4 weeks - NCT06824350Recruiting
Chlorine in water to prevent newborn infections
This trial tests whether adding a small amount of chlorine to the drinking water at public health facilities can reduce infections (including those resistant to antibiotics) in newborns. You and your baby may be eligible if you deliver at a participating facility that does not already chlorinate its water.
Berkeley, CaliforniaAges Any age - NCT06771206Recruiting
Testing a new oxygen sensor in newborns
This study checks how well a new Owlet sensor measures oxygen levels in newborns. It is for babies who already have an arterial line in place for routine blood tests.
Birmingham, AlabamaAges birth–4 weeks - NCT06750536Recruiting
Safety study of a new lung support device for small children
This trial is testing a new device (MiniLung Petite Kit) for babies and young children with severe lung or heart failure. The device helps oxygenate the blood and remove carbon dioxide, giving the lungs and heart a chance to rest and heal.
Bonn, North Rhine-WestphaliaAges Up to 8 months - NCT06726408Recruiting
Better brain monitoring for babies in the ICU
This study tests a new way to monitor the brains of very young children (under 2 years old) in the ICU. It aims to give doctors better information to help protect your child's brain.
NantesAges Up to 2 years - NCT06533098RecruitingPhase 3
Nipocalimab vs IVIG for FNAIT in pregnancy
This study tests a new medicine called nipocalimab compared to standard IVIG treatment for pregnant women who are at risk of a serious condition where the mother's antibodies attack the baby's platelets (FNAIT). The goal is to see if nipocalimab can prevent complications like bleeding in the baby.
Birmingham, AlabamaAges 18–45 - NCT06464588RecruitingPhase 1
Testing safety of newborn stem cells for dilated cardiomyopathy in young adults and children
This study tests whether a single intravenous infusion of stem cells from donated newborn tissue is safe for people aged 4 to 39 with dilated cardiomyopathy (a weakened, enlarged heart). It aims to find a new option for those who haven't improved enough with standard heart failure medications.
Atlanta, GeorgiaAges 4–40 - NCT06449651RecruitingPhase 3
Nipocalimab to prevent low platelets in newborns
This study tests a medicine called nipocalimab for pregnant women whose babies are at risk of a bleeding condition called FNAIT. The medicine may help prevent low platelet counts and serious bleeding in the newborn.
LeuvenAges 18–45 - NCT05226624Recruiting
Improving care for babies born with opioid withdrawal
This program helps participating hospitals improve care for newborns who may go through opioid withdrawal (also called neonatal abstinence syndrome). It mainly aims to make mother-baby support and treatment plans work better after delivery.
Edmonton, AlbertaAges Any age - NCT06303986Enrolling by invitation
Observation study for newborns with or without NAS
This study is collecting information from two groups of newborns: those with Neonatal Abstinence Syndrome (NAS, caused by drug exposure before birth) and healthy newborns. The goal is to see if an automated system makes it easier to gather data without extra tests or procedures.
Albuquerque, New MexicoAges Up to 4 weeks - NCT06087224Recruiting
Telemedicine for newborn emergencies
This study tests if a telemedicine system helps community hospital teams care for newborns who need advanced help right after birth. It may improve care for premature babies or those needing breathing or chest support.
Anchorage, AlaskaAges birth+ - NCT06098833RecruitingPhase 2
Sildenafil for newborn brain injury after birth asphyxia
This trial tests whether a liquid form of the medicine sildenafil can help repair brain damage in newborns who had a difficult birth and were treated with cooling. If your baby meets the cooling criteria and has brain injury on an MRI, this study may offer an additional treatment option.
Denver, ColoradoAges birth–2 days - NCT05371886Recruiting
Testing how morphine (with or without midazolam) behaves in NICU babies
This study measures how morphine works in very young babies, and whether adding midazolam changes how the medicines behave and affect the body. It may help doctors better choose and dose pain/sedation medicines for babies in intensive care.
BrestAges 5 months–10 months - NCT05896306Recruiting
Monitor blood flow in newborns during resuscitation
This study uses a painless light-based monitor to track how blood is moving in the brains of newborns during resuscitation. It may help doctors better understand what’s happening during care for very sick newborns.
Graz, StyriaAges birth–15 minutes - NCT05889507RecruitingPhase 3
Cooling treatment for newborns with mild brain injury
This Phase 3 study tests whether cooling a newborn’s body can help babies with mild brain injury after a difficult birth. It aims to see if cooling improves brain-related outcomes compared with standard care.
NaplesAges 1 hour–6 hours - NCT05836610RecruitingPhase 4
Testing hydrocortisone dosing during newborn cooling
This Phase 4 trial studies the best way to give hydrocortisone (a steroid medicine) to newborns who are being cooled for a specific kind of birth-related lack of oxygen. It’s for babies who have low blood pressure during cooling, aiming to improve their stability while they receive standard treatment.
Budapest, Pest CountyAges Up to 3 days - NCT05843396Recruiting
Study of newborn brain development and response to care
This study looks at how newborns’ brains develop and how they respond to an intervention. It helps researchers understand brain organization in individual babies so care can improve in the future.
Minneapolis, MinnesotaAges Any age - NCT05673499Recruiting
Monitoring oxygen and brain signals during major newborn surgery
This study checks how well newborn babies’ brains are getting oxygen and how brain activity changes while they have certain major surgeries. It may help doctors better monitor brain safety during surgery in newborns with specific conditions.
New York, New YorkAges Up to 1.1 years - NCT05187897Recruiting
Text-message support for healthy pregnancy and newborn care
This study tests whether regular text messages during pregnancy and after birth can help with neonatal (newborn) health. You may qualify if you’re in the right stage of pregnancy, can receive texts, and plan to stay nearby for a few months after delivery.
KisumuAges 14 years+ - NCT05514340RecruitingPhase 2
Test drug for brain injury after low oxygen at birth
This Phase 2 study tests whether sovateltide can improve safety and outcomes for babies whose brains may have been injured by low oxygen around birth. It focuses on babies who show signs of moderate to severe injury soon after delivery, and who receive standard supportive care.
Mangalore, KarnatakaAges Any age - NCT04393701Recruiting
Testing newborn blood spots to check for rare storage diseases
This pilot study tries a systematic way to look for several rare “lysosomal storage” diseases in newborns using a specialized lab test on routine blood samples. It may help detect these conditions earlier so treatment can start sooner if needed.
CaenAges 1 day–4 days
Hear when a new Neonate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neonate?
- Yes. Clin2 currently lists 319 recruiting neonate studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neonate trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neonate trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.